MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 56 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,391 | -85.6% | 24,726 | -86.0% | 0.02% | -85.9% |
| Q2 2023 | $225,044 | +71.6% | 177,200 | 0.0% | 0.18% | +71.8% |
| Q1 2023 | $131,128 | -1.3% | 177,200 | 0.0% | 0.10% | +2.0% |
| Q4 2022 | $132,900 | -13.1% | 177,200 | 0.0% | 0.10% | -48.2% |
| Q3 2022 | $153,000 | – | 177,200 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 2,188,606 | $1,641,455 | 0.95% |
| Monaco Asset Management SAM | 2,049,661 | $1,537,246 | 0.46% |
| Rubric Capital Management LP | 10,366,120 | $7,774,590 | 0.34% |
| Clearline Capital LP | 2,052,709 | $1,539,532 | 0.28% |
| DAFNA Capital Management LLC | 1,096,513 | $822,385 | 0.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $5,523,329 | 0.23% |
| Orbimed Advisors | 10,605,522 | $7,954,142 | 0.15% |
| Octagon Capital Advisors LP | 1,000,000 | $750,000 | 0.12% |
| Rock Springs Capital Management LP | 6,244,897 | $4,683,673 | 0.11% |
| Privium Fund Management (UK) Ltd | 177,200 | $132,900 | 0.10% |